Bio-Rad ddPCR KRAS Screening Multiplex Kit
Bio-Rad Laboratories has launched the ddPCR KRAS Screening Multiplex Kit, the latest offering in the company’s Droplet Digital PCR line of predesigned, fully wet-lab validated assays. The kit offers improved sensitivity and simultaneous detection of the seven most common KRAS mutations in a single ddPCR experiment.
KRAS mutations are found in 90% of pancreatic cancer cases and 30% of colorectal cancer cases, making it a gene of interest to cancer researchers. Used with Bio-Rad’s ddPCR technology, the multiplex kit is able to detect and quantify extremely low levels (down to 0.2%) of KRAS mutant DNA in a single assay. Cancer samples are often available in limited quantities, and the kit enables researchers to derive results from low amounts of starting material.
The product delivers a simple yes/no answer as to whether a KRAS mutation exists in smaller samples. It allows researchers to screen for multiple mutations in a single reaction, saving time and resources. The kit is compatible with all of Bio-Rad’s Droplet Digital PCR Systems, including the QX200 AutoDG Droplet Digital PCR System.
Phone: 02 9914 2800
Rivzman Solutions presents a tool for the calibration of what is claimed to be the world's...
UltraFlux RT is a clear polyolefin film suitable for real-time PCR.
Chemical Safety International (formerly ACOHS) is offering an expanded range of chemical safety...